Glitazone-like action of glimepiride and glibenclamide in primary human adipocytes
Diabetes, Obesity and Metabolism, 08/22/2011
Mayer P et al. – In primary human pre–adipocytes, glibenclamide and glimepiride strongly induced differentiation, apparently by activating peroxisome proliferator–activated receptor gamma (PPARgamma). Thus, Sulphonylureas (SUs) but not repaglinide may be used to influence insulin resistance beyond their effect on insulin liberation.







